Notícias Aclarion Inc - ACONW | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Aclarion Inc (ACONW)
Aclarion Inc (ACONW) Notícias

Aclarion Inc (ACONW)

0,0868

0,0018

(2,12%)

Fechado 06 Março 6:00PM

Atrasado por 15 minutos

0,089102

0,0023

(2,65%)

Após o horário de negociação: 9:52PM

Atrasado por 15 minutos

Seu centro para cotações em tempo real, discussões ao vivo e novas ideias.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs

Aclarion Announces Closing of $3.0 Million Public Offering

Aclarion Announces Pricing of $3.0 Million Public Offering

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

Aclarion Announces Reverse Stock Split

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Aclarion Presents at the NIH HEAL Initiative Fall Meeting

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

3
4
5
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Intesa Sanpaolo

Intesa Sanpaolo

Vontobel Financial Produ...

Societe Generale Effekten

Societe Generale Effekten

Societe Generale Effekten

BNP Paribas Issuance

Societe Generale Effekten

Societe Generale Effekten

Vontobel Financial Produ...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições